Tel 400-9988-900
Home > News > Company News > Over 130 Global Pharma Leaders Came to Our Doorstep — Here’s What Happened at Truking’s 2025 Global Open House Day
Aug 15, 2025

Over 130 Global Pharma Leaders Came to Our Doorstep — Here’s What Happened at Truking’s 2025 Global Open House Day

Over 130 Global Pharma Leaders Came to Our Doorstep — Here’s What Happened at Truking’s 2025 Global Open House Day

 

From June 26 to 28, Truking Technology’s China headquarters in Changsha welcomed pharmaceutical executives from nearly 30 countries across Asia, Europe, North and South America, and North Africa.

This wasn’t just a site visit—it was a global convergence of insight, innovation, and ambition. Over three days, we opened our doors to showcase what we’re building, listen to what the world needs, and co-create the future of pharmaceutical manufacturing.

 

Global Forum: Innovation Meets Vision

A highlight of the Open House Day was the Global Forum on Integrated Pharmaceutical Solutions, where industry experts, city leaders, and Truking’s top engineers came together for a future-facing conversation on pharmaceutical technology.

Mr. Zhang Zuolin, First-hand of Ningxiang Government, addressed the international audience:

“Truking is a benchmark enterprise in Ningxiang and a key contributor to the global health industry. Ningxiang will continue to support international collaboration and provide an open platform for innovation.”

 

From our side, Truking President Mr. Tang Yue emphasized not just scale, but philosophy:

“We’re a young company that has grown with global DNA. In over 25 years, we’ve built end-to-end capabilities—from biopharma to chemical APIs, from design to verification. But our most important asset is the insights we gain from our customers. Your valuable feedback make us better.”

 

Innovation in Focus: New Vial Line Debuts

During the event, we unveiled Truking’s latest generation of vial filling and sealing solutions, developed to meet the highest global standards for precision, speed, and sterility. These innovations mark our continued investment in next-gen aseptic technology for both small and large molecule production.

Online message Top
Close
TitleOnsite installation

Online message

Close
Titlejoin us

join us